I tend to agree, but try to restrict it to people of a similar disposition (not everyone's cuppa). IMO it's likely to be a while till there's any significant news from China, without adequate advertising I don't see any European/UK products being anything but niche, so I guess PXS wait for news on memory trial results. My concern would be that positive memory loss news is unlikely to result in a substantial increase in SP, but negative news would likely hit it significantly (good buying… Read More
Not sure what a "wat" is but sounds like a comment normally made by the ill educated. Lots of research goes on here, you just have to read some of the worthy posts. Might want to do some research yourself? Newbie????????????
It's boring without winding people up. Anyway when is there any news due on this. I've never been back in since they did their crazy spike. I could never buy as a normal long term investment but it's good to buy when there is a sniff of news or the rampers are out in force. Apart from my long term investments I've found myself very impatient with these aim shares that are ramped and don't like to hold for longer than a couple of weeks.
Like I stated previously, it's not your stories I struggle to comprehend (all perfectly feasible), it's your desire to keep trotting them out to people you don't know. Besides, there's no need to get yourself in a lather, you openly state you're here to wind people up lol
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.